Want to join the conversation?
$C said that for FY16, the company expects its operating efficiency ratio to be higher than anticipated at 58%. In the consumer side, $C continues to expect to achieve YoverY revenue growth in the existing US branded cards and Asia cards businesses in 2H16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.